The American Journal of Medicine
Volume 121, Issue 4 , Pages 279-281 , April 2008

Age-related Macular Degeneration: An Update on Treatment

References 

  1. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: the Beaver Dam eye study. Ophthalmology. 1992;99:933–943
  2. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five-year results from randomized clinical trials. Arch Ophthalmol. 1991;109:1109–1114
  3. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol. 1986;104:503–512
  4. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with vertiporfin: one-year results of 2 randomized clinical trials-TAP report 1. Arch Ophthalmol. 1999;117:1329–1345
  5. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol. 2001;119:198–207
  6. Gragoudas ES, Adamis AP, Cunningham ET, et al. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805–2816
  7. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36:331–335
  8. Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina. 2006;26:383–390
  9. Freeman WR, Falkenstein I. Avastin and new treatments for AMD: where are we?. Retina. 2006;26:853–857
  10. Rosenfeld PJ, Brown DM, Heier JS, et al. MARINA Study Group Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431
  11. Brown DM, Kaiser PK, Michels M, et al. ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–1444

 Richard D. deShazo, MD, Specialty Editor

PII: S0002-9343(07)01090-X

doi: 10.1016/j.amjmed.2007.10.020

The American Journal of Medicine
Volume 121, Issue 4 , Pages 279-281 , April 2008

Article Tools

* Image Usage & Resolution